Beam Therapeutics to Participate in Upcoming May Investor Conferences

CAMBRIDGE, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will participate in fireside chats during the following May investor conferences:

• BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022, at 2:00 p.m. PT in Las Vegas; and,
• 2022 RBC Capital Markets Global Healthcare Conference on Tuesday, May 17, 2022, at 2:35 p.m. ET in NYC.

Live webcasts will be available in the investor section of the company's website at www.beamtx.com, and will be archived for 60 days following the presentation.

About Beam TherapeuticsBeam Therapeutics (Nasdaq: BEAM) is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that enables precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.

Contacts:

Investors:Chelcie ListerTHRUST Strategic Communications[email protected] 

Media:Dan Budwick1AB[email protected] 

You May Also Be Interested In

• 2026 Pujiang Innovation Forum Opens in Shanghai
• Credible Captain Launches Independent Consumer Review Platform Focused on Transparency, AI, and Trust
• Hooker Furnishings Reports Profitable Quarter and First Half